DALLAS, May 25 /PRNewswire-FirstCall/ -- BioTech Medics, Inc., (OTC Pink Sheets: BTMD) announced today that they have made a presentation to doctors and staff at the Muenster Memorial Hospital...
DALLAS, May 12 /PRNewswire/ -- BioTech Medics, Inc., has contacted the Center for Disease Control in Atlanta to seek testing of SHBAN Solution as an anti-viral disinfectant in killing the Avian...
DALLAS, April 26 /PRNewswire-FirstCall/ -- The Board of Directors of BioTech Medics, Inc. (OTC Pink Sheets: BTMD) announced that the company has signed an Engagement Letter with Moore and...
DALLAS, Feb. 13 /PRNewswire-FirstCall/ -- BioTech Medics, Inc., (OTC Pink Sheets: BTMD) announces that it has entered into a Letter of Intent with the Owners to acquire nearly 6 acres and over...
DALLAS, Feb. 7 /PRNewswire-FirstCall/ -- BioTech Medics, Inc. (OTC Pink Sheets: BTMD) has entered into a Letter of Intent to acquire specified BioBody Product formula, trademarks and copyrights...
DALLAS, Jan. 17 /PRNewswire-FirstCall/ -- BioTech Medics, Inc. (OTC Pink Sheets: BTMD), announces the hiring of BUYINS.NET. (http://www.buyins.net/ ). BUYINS.NET is initiating coverage of (OTC...
DALLAS, Jan. 11 /PRNewswire-FirstCall/ -- BioTech Medics, Inc. (OTC Pink Sheets: BTMD) announced that the company, as Defendant, had been served with a Texas civil defamation action by Adam...
DALLAS, Dec. 9 /PRNewswire-FirstCall/ -- Keith Houser, CEO of BioTech Medics, Inc., (OTC Pink Sheets: BTMD) issued a statement chronicling the accomplishments during the first year anniversary...
DALLAS, Nov. 21 /PRNewswire-FirstCall/ -- Keith Houser, CEO of BioTech Medics, Inc., (OTC Pink Sheets: BTMD) announced that BTMD signed a contract with Optininvestors. "Optininvestors a...
DALLAS, Nov. 10 /PRNewswire-FirstCall/ -- Charles R. Crane, MD, President & Medical Director of BioTech Medics, Inc., (OTC Pink Sheets: BTMD) announced today a significant finding while treating...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관